We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.
- Authors
Angiolillo, Dominick J; Badimon, Juan Jose; Saucedo, Jorge F; Frelinger, Andrew L; Michelson, Alan D; Jakubowski, Joseph A; Zhu, Baojin; Ojeh, Clement K; Baker, Brian A; Effron, Mark B
- Abstract
Patients with diabetes mellitus (DM) have increased platelet reactivity and reduced platelet response to clopidogrel compared with patients without DM. Prasugrel, a more potent antiplatelet agent, is associated with greater reductions in ischaemic events compared with clopidogrel, particularly in patients with DM. The aim of this study was to perform serial pharmacodynamic assessments of prasugrel with high-dose clopidogrel in patients with DM.
- Publication
European heart journal, 2011, Vol 32, Issue 7, p838
- ISSN
1522-9645
- Publication type
Journal Article
- DOI
10.1093/eurheartj/ehq494